Comparator Sourcing In Emerging Markets: Look Before You Leap
Source: Thermo Fisher Scientific

By Khaled El-Gendy, Fisher Clinical Services
The broad appeal of emerging markets for comparator sourcing is offset by the innumerable challenges that can arise in such regions. By addressing concerns prior to the jump into uncharted territory, risks can be minimised and common pitfalls avoided.
As the volume, size and complexity of clinical trials in emerging markets reaches record levels, the demand for reference drugs – or so-called comparators – is soaring, putting supply chain professionals under pressure to source sufficient quantities of these products against tight timeframes and budget constraints.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more